Clinical trial
Combined Nortriptyline and Transdermal Nicotine for Smoking Cessation
NCT00018148 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00018148 |
|---|---|
| Title | Combined Nortriptyline and Transdermal Nicotine for Smoking Cessation |
| Official title | Combined Nortriptyline and Transdermal Nicotine for Smoking Cessation |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Smoking |
| Intervention type | Drug |
| Interventions | nortriptyline, transdermal nicotine |
| Enrollment | 158 |
| Start date | Apr 1, 1998 |
| Primary completion | Dec 1, 2002 |
| Completion | Jan 1, 2003 |
| First posted | Jul 5, 2001 |
| Last update posted | Sep 15, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: